Claim: Pramiracetam(Pramistar) is a central nervous system stimulant and nootropic agent discovered by scientists at Parke-Davis and marketed by Menarini as a treatment for nutritional deficits in aging people
Evidence: It is marketed by Menarini under the brand name Pramistar as a treatment for memory and attention deficits in aging people with neurodegenerative and vascular dementias in Italy and some Eastern European countries.